|
Please click on links below for a webcast of the event.(Please use Internet Explorer) Day 1.
Session 1 -Overview Session 2 -CAPRISA Aids Treatment Research. P Buthelezi G Churchyard M Khan B Mdluli K Naidoo N Padayatchi R Perumal V Naranbhai Discussion Acknowledgements Day 2 Session 3 -CAPRISA HIV Pathogenesis & Vaccine Research. Natural HIV disease progression following acute HIV infection- ( K Mlisana) Virology factors impacting disease progression- (Z Woodman) The Fluid Nature of HIV-1 specific T cell response- (C Gray) Evolution of neutralizing antibody responses.- (Lynn Morris) Host Factors in Primary HIV-1 Infection - (Thumbi N) What have we learnt in the CAPRISA Acute Infection- (SS Abdool Karim) Immune activation and disease progression - (W Burgers) Genital tract inflammation- Correlation with disease- (J Passmore) Role of IL-10 promoter polymorphisms in acute infection- (D Naicker) Discussion on Acute HIV infection1 Discussion on Acute HIV infection2 Caprisa summary April 2009 Des Martin Acknowledgements Session 4 -CAPRISA Epidemiology & Prevention Research.
Epidemiology of HIV infection in Vulindlela- Rationale for the RHIVA trail- (Q Abdool Karim) Discussion on HIV prevention in adolescents 1 Discussion on HIV prevention in adolescents 2 Discussion on HIV prevention in adolescents 3 Session 5 -CAPRISA Microbicide Research.
Historical overview of Microbicides- (SS Abdool Karim) Overview of the CAPRISA 004 - Tenofovir Gel Microbicide trial- (Q Abdool Karim) Updates & Young Investigator presentations: Overview of the TRAPS Programme- (S Sibeko) NK cells and HIV prevention - Impact of Tenofovir- (V Naranbhai) HIV Infection and Tenofovir in the genital mucosa- (A Naicker) Tenofovir gel and Hepatitis B infection – (C Baxter) Discussion on microbicides_session Summary of Microbicide discussion_Session 5- (H Gabelnick) Acknowledgements Closure & Vote of Thanks- (J Darbyshire / C Hankins)
|
